PortalPublikationenCombination of osteopontin and activated leukocyte cell adhe...

Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer.

Standard

Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer. / Henningsen, Maike; Wirtz, R M; Kalogeras, K T; Milde-Langosch, Karin; Schmidt, M; Witzel, Isabell; Eleftheraki, A G; Papadimitriou, C; Jänicke, Fritz; Briassoulis, E; Pectasides, D; Rody, A; Fountzilas, G; Müller, Volkmar.

in: BRIT J CANCER, Jahrgang 103, Nr. 7, 7, 2010, S. 1048-1056.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Henningsen, M, Wirtz, RM, Kalogeras, KT, Milde-Langosch, K, Schmidt, M, Witzel, I, Eleftheraki, AG, Papadimitriou, C, Jänicke, F, Briassoulis, E, Pectasides, D, Rody, A, Fountzilas, G & Müller, V 2010, 'Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer.', BRIT J CANCER, Jg. 103, Nr. 7, 7, S. 1048-1056. <http://www.ncbi.nlm.nih.gov/pubmed/20736952?dopt=Citation>

APA

Henningsen, M., Wirtz, R. M., Kalogeras, K. T., Milde-Langosch, K., Schmidt, M., Witzel, I., Eleftheraki, A. G., Papadimitriou, C., Jänicke, F., Briassoulis, E., Pectasides, D., Rody, A., Fountzilas, G., & Müller, V. (2010). Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer. BRIT J CANCER, 103(7), 1048-1056. [7]. http://www.ncbi.nlm.nih.gov/pubmed/20736952?dopt=Citation

Vancouver

Henningsen M, Wirtz RM, Kalogeras KT, Milde-Langosch K, Schmidt M, Witzel I et al. Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer. BRIT J CANCER. 2010;103(7):1048-1056. 7.

Bibtex

@article{6d267aca5fe64f578f9f40d1c3ef1373,
title = "Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer.",
abstract = "To analyse the discriminative impact of osteopontin (OPN) and activated leukocyte cell adhesion molecule (ALCAM), combined with human epidermal growth factor 2 (HER2) and oestrogen receptor (ER) in breast cancer.",
author = "Maike Henningsen and Wirtz, {R M} and Kalogeras, {K T} and Karin Milde-Langosch and M Schmidt and Isabell Witzel and Eleftheraki, {A G} and C Papadimitriou and Fritz J{\"a}nicke and E Briassoulis and D Pectasides and A Rody and G Fountzilas and Volkmar M{\"u}ller",
year = "2010",
language = "Deutsch",
volume = "103",
pages = "1048--1056",
journal = "BRIT J CANCER",
issn = "0007-0920",
publisher = "NATURE PUBLISHING GROUP",
number = "7",

}

RIS

TY - JOUR

T1 - Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer.

AU - Henningsen, Maike

AU - Wirtz, R M

AU - Kalogeras, K T

AU - Milde-Langosch, Karin

AU - Schmidt, M

AU - Witzel, Isabell

AU - Eleftheraki, A G

AU - Papadimitriou, C

AU - Jänicke, Fritz

AU - Briassoulis, E

AU - Pectasides, D

AU - Rody, A

AU - Fountzilas, G

AU - Müller, Volkmar

PY - 2010

Y1 - 2010

N2 - To analyse the discriminative impact of osteopontin (OPN) and activated leukocyte cell adhesion molecule (ALCAM), combined with human epidermal growth factor 2 (HER2) and oestrogen receptor (ER) in breast cancer.

AB - To analyse the discriminative impact of osteopontin (OPN) and activated leukocyte cell adhesion molecule (ALCAM), combined with human epidermal growth factor 2 (HER2) and oestrogen receptor (ER) in breast cancer.

M3 - SCORING: Zeitschriftenaufsatz

VL - 103

SP - 1048

EP - 1056

JO - BRIT J CANCER

JF - BRIT J CANCER

SN - 0007-0920

IS - 7

M1 - 7

ER -